Redo‐Transcatheter Aortic Valve Replacement With a 26 mm Sapien Valve in a 26 mm Evolut Valve to Correct Significant Paravalvular Leak via Transcarotid Access

An 84-year-old man with multiple comorbidities including severe aortic stenosis, heart failure with a reduced ejection fraction, severe peripheral artery disease with prior bilateral iliac artery stents, and trifascicular block presented for evaluation for aortic valve replacement. He was deemed high risk for surgical valve replacement. Preprocedural computed tomography angiography (CTA) for transcatheter aortic valve replacement (TAVR) planning demonstrated an annular area of 295 mm<sup>2</sup> and perimeter of 62 mm. There was significant slice misregistration on CT; thus, we performed multiple re-measurements in different phases of the cardiac cycle. The patient sized for either a 23 mm Evolut FX+ (16% oversizing) or a 26 mm Evolut FX+ (30% oversizing). The left and right coronary artery heights were 17 and 19 mm, respectively. Transfemoral access was not possible due to severely calcified stenotic lesions with a maximal diameter of 4.6 and 3.8 mm in the right and left common iliac artery, respectively. He underwent dual-chamber permanent pacemaker implantation 5 weeks before scheduled TAVR. With a multidisciplinary heart valve team, the patient underwent left transcarotid TAVR with a 26 mm Evolut FX+ valve with resultant moderate-severe paravalvular leak on transesophageal echocardiography (TEE) that did not improve despite multiple post-dilations with 22- and 24-mm balloons at the inflow of the valve. At this point, we re-evaluated the preprocedural CT, utilizing the noncardiac gated series which showed less slice misregistration. The annular area measured 504 mm<sup>2</sup> with a perimeter of 80 mm, thus sizing for a 26 mm Sapien 3 Ultra (3% oversizing). The next day, the patient underwent successful left transcarotid valve-in-valve TAVR with a 26 mm Sapien 3 Ultra valve deployed with the outflow positioned at node 6 of the Evolut valve. The valve was post-dilated with a 25 mm balloon, resulting in no paravalvular leak on TEE. This case highlights a safe and effective strategy to correct significant PVL post-TAVR with a larger 26 mm Sapien 3 Ultra valve inside a 26 mm Evolut FX+ valve.

Authors

Institutions

Publication Details

Journal
Catheterization and Cardiovascular Interventions
Published
2025-09-23
DOI
https://doi.org/10.1002/ccd.70212
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Redo‐Transcatheter Aortic Valve Replacement With a 26 mm Sapien Valve in a 26 mm Evolut Valve to Correct Significant Paravalvular Leak via Transcarotid Access

Angela Lowenstern, Aaron Williams, Charlene L. Rohm, Susan S. Eagle et al.
Catheterization and Cardiovascular Interventions
Cardiac Valve Diseases and Treatments
article

Redo‐Transcatheter Aortic Valve Replacement With a 26 mm Sapien Valve in a 26 mm Evolut Valve to Correct Significant Paravalvular Leak via Transcarotid Access

Angela Lowenstern, Aaron Williams, Charlene L. Rohm, Susan S. Eagle, Ahmed Eid
article en

Abstract

An 84-year-old man with multiple comorbidities including severe aortic stenosis, heart failure with a reduced ejection fraction, severe peripheral artery disease with prior bilateral iliac artery stents, and trifascicular block presented for evaluation for aortic valve replacement. He was deemed high risk for surgical valve replacement. Preprocedural computed tomography angiography (CTA) for transcatheter aortic valve replacement (TAVR) planning demonstrated an annular area of 295 mm<sup>2</sup> and perimeter of 62 mm. There was significant slice misregistration on CT; thus, we performed multiple re-measurements in different phases of the cardiac cycle. The patient sized for either a 23 mm Evolut FX+ (16% oversizing) or a 26 mm Evolut FX+ (30% oversizing). The left and right coronary artery heights were 17 and 19 mm, respectively. Transfemoral access was not possible due to severely calcified stenotic lesions with a maximal diameter of 4.6 and 3.8 mm in the right and left common iliac artery, respectively. He underwent dual-chamber permanent pacemaker implantation 5 weeks before scheduled TAVR. With a multidisciplinary heart valve team, the patient underwent left transcarotid TAVR with a 26 mm Evolut FX+ valve with resultant moderate-severe paravalvular leak on transesophageal echocardiography (TEE) that did not improve despite multiple post-dilations with 22- and 24-mm balloons at the inflow of the valve. At this point, we re-evaluated the preprocedural CT, utilizing the noncardiac gated series which showed less slice misregistration. The annular area measured 504 mm<sup>2</sup> with a perimeter of 80 mm, thus sizing for a 26 mm Sapien 3 Ultra (3% oversizing). The next day, the patient underwent successful left transcarotid valve-in-valve TAVR with a 26 mm Sapien 3 Ultra valve deployed with the outflow positioned at node 6 of the Evolut valve. The valve was post-dilated with a 25 mm balloon, resulting in no paravalvular leak on TEE. This case highlights a safe and effective strategy to correct significant PVL post-TAVR with a larger 26 mm Sapien 3 Ultra valve inside a 26 mm Evolut FX+ valve.

Catheterization and Cardiovascular InterventionsVol. 106(6)
Vanderbilt University Medical Center (US)
Openalex Percentile: Top 60%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.